Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Dialectical behaviour therapy for suicidal individual: The international perspective 

Dialectical behaviour therapy for suicidal individual: The international perspective
Chapter:
Dialectical behaviour therapy for suicidal individual: The international perspective
Author(s):

Barbara Stanley

and Beth S Brodsky

DOI:
10.1093/med/9780198570059.003.0057
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 August 2021

Dialectical behaviour therapy (DBT) is an outpatient, cognitive behavioural treatment shown to reduce self-injury and suicidal behaviour in individuals with borderline personality disorder (BPD). In this chapter, we review the basic principles of the DBT approach to the treatment of suicidal individuals, and the status of DBT treatment and research from an international perspective. The diagnostic criteria for BPD (developed and validated in the US) have been found to be applicable to and prevalent among various populations worldwide. The efficacy of DBT in reducing suicidal behaviour in individuals with BPD has led to its widespread adaptation in clinical settings all over the world. International clinical research teams are conducting randomized clinical trials to further test DBT’s efficacy in reducing suicidal behaviour and associated symptomatology in borderline populations.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.